Elephantiasis, Filarial

Phase 4 trials (3)

• albendazole
• ivermectin
• azithromycin

Phase 3 trials (6)

• decitabine
• doxycycline
• diethylcarbamazine
• piperaquine
• moxidectin
• dihydroartemisinin

Phase 1 trials (1)

• awz1066s

Organization Involved with Phase 4 Indications (10)

• World Health Organization
• Armauer Hansen Research Institute, Ethiopia
• Centre d'Appui à la lutte contre la Maladie
• University of London
• Emory University
• Ghana Health Services
• Noguchi Memorial Institute for Medical Research
• Malaria Research and Training Center, Bamako, Mali
• Federal Ministry of Health, Ethiopia
• Government of Mozambique

Organization Involved with Phase 3 Indications (11)

• The Task Force for Global Health
• Centre Muraz
• Case Western Reserve University
• Lihir Medical Centre
• Colorado State University
• Neglected Tropical Disease Support Center
• Washington University in St. Louis
• United States Agency for International Development
• Government of Papua New Guinea
• Institut et Haute école de la Santé, La Source
• Regional Hospital of Agboville, Southern Cote d'Ivoire

Organization Involved with Phase 2 Indications (3)

• National Institute of Allergy and Infectious Diseases (NIAID)
• Papua New Guinea Institute of Medical Research
• National Institute for Research in Tuberculosis, Chennai, India

Organization Involved with Other Experimental Indications (8)

• Indian Council of Medical Research
• University of Copenhagen
• Centre National d'Appui à la Lutte contre la Maladie, Mali
• Murdoch University
• International Trachoma Initiative
• Danish Council for Development Research
• The AIDS Foundation, Denmark
• The Wedell-Wedellsborg Foundation, Denmark